SARS–CoV-2 immuno-pathogenesis and potential for diverse vaccines and therapies: opportunities and challenges
Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is a novel coronavirus
that emerged from Wuhan, China in late 2019 causing coronavirus disease-19 (COVID-19) …
that emerged from Wuhan, China in late 2019 causing coronavirus disease-19 (COVID-19) …
Immunobiology and nanotherapeutics of severe acute respiratory syndrome 2 (SARS-CoV-2): a current update
IE Mba, HC Sharndama, GO Osondu-Chuka… - Infectious …, 2021 - Taylor & Francis
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
constitutes the most significant global public health challenge in a century. It has reignited …
constitutes the most significant global public health challenge in a century. It has reignited …
[PDF][PDF] Combating the challenges of COVID-19 pandemic: Insights into molecular mechanisms, immune responses and therapeutics against SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection causes lethal
coronavirus disease (COVID-19). SARS-CoV-2 has been the chief source of threat to public …
coronavirus disease (COVID-19). SARS-CoV-2 has been the chief source of threat to public …
Investigating virological, immunological, and pathological avenues to identify potential targets for developing covid-19 treatment and prevention strategies
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an emerging
coronavirus causing respiratory disease commonly known as COVID-19. This novel …
coronavirus causing respiratory disease commonly known as COVID-19. This novel …
SARS‐CoV‐2‐mediated immune system activation and potential application in immunotherapy
Y Tan, F Tang - Medicinal research reviews, 2021 - Wiley Online Library
Although novel severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)‐mediated
pulmonary inflammation has recently attracted great attention, its pathology and …
pulmonary inflammation has recently attracted great attention, its pathology and …
The trinity of COVID-19: immunity, inflammation and intervention
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of
the ongoing coronavirus disease 2019 (COVID-19) pandemic. Alongside investigations into …
the ongoing coronavirus disease 2019 (COVID-19) pandemic. Alongside investigations into …
[HTML][HTML] SARS-CoV-2 infection and immune responses
R Harne, B Williams, HFM Abdelaal, SL Baldwin… - AIMS …, 2023 - ncbi.nlm.nih.gov
The recent pandemic caused by the SARS-CoV-2 virus continues to be an enormous global
challenge faced by the healthcare sector. Availability of new vaccines and drugs targeting …
challenge faced by the healthcare sector. Availability of new vaccines and drugs targeting …
Potential therapeutic targets and vaccine development for SARS-CoV-2/COVID-19 pandemic management: a review on the recent update
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a highly pathogenic
novel virus that has caused a massive pandemic called coronavirus disease 2019 (COVID …
novel virus that has caused a massive pandemic called coronavirus disease 2019 (COVID …
Pharmaceutical aspects and clinical evaluation of COVID-19 vaccines
ABSTRACT COVID-19, the disease caused by the novel severe acute respiratory syndrome-
associated coronavirus 2 (SARS-CoV-2), was first detected in December 2019 and has …
associated coronavirus 2 (SARS-CoV-2), was first detected in December 2019 and has …
[HTML][HTML] COVID‐19: Current knowledge in clinical features, immunological responses, and vaccine development
R Singh, A Kang, X Luo, M Jeyanathan… - The FASEB …, 2021 - ncbi.nlm.nih.gov
The COVID‐19 pandemic has unfolded to be the most challenging global health crisis in a
century. In 11 months since its first emergence, according to WHO, the causative infectious …
century. In 11 months since its first emergence, according to WHO, the causative infectious …